163 related articles for article (PubMed ID: 23648814)
1. Massive soft tissue calcifications in severe hyperparathyroidism secondary to end-stage renal disease.
Staszków M; Wojtaszek E; Żebrowski P; Matuszkiewicz-Rowińska J
Pol Arch Med Wewn; 2013; 123(4):191-2. PubMed ID: 23648814
[No Abstract] [Full Text] [Related]
2. Regression of parathyroid gland swelling by treatment with cinacalcet.
Terawaki H; Nakano H; Takeguchi F; Hasegawa T; Nakayama M; Okazaki M; Hosoya T
Nephrol Dial Transplant; 2009 Feb; 24(2):690-1; author reply 691-2. PubMed ID: 18987257
[No Abstract] [Full Text] [Related]
3. [Secondary hyperparathyroidism].
Imanishi Y; Inaba M
Nihon Rinsho; 2006 Jun; Suppl 2():31-6. PubMed ID: 16817344
[No Abstract] [Full Text] [Related]
4. Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan.
Iseki K
Expert Opin Pharmacother; 2008 Mar; 9(4):601-10. PubMed ID: 18312161
[TBL] [Abstract][Full Text] [Related]
5. Association of nodular hyperplasia with resistance to cinacalcet therapy for secondary hyperparathyroidism in hemodialysis patients.
Hirai T; Nakashima A; Takasugi N; Yorioka N
Ther Apher Dial; 2010 Dec; 14(6):577-82. PubMed ID: 21118366
[TBL] [Abstract][Full Text] [Related]
6. Tumoral calcinosis in renal failure.
Lin WT; Chao CM
QJM; 2014 May; 107(5):387. PubMed ID: 23904519
[No Abstract] [Full Text] [Related]
7. Tertiary hyperparathyroidism resistant to cinacalcet treatment.
Okada M; Tominaga Y; Izumi K; Nobata H; Yamamoto T; Hiramitsu T; Tsujita M; Goto N; Nanmoku K; Watarai T; Uchida K
Ther Apher Dial; 2011 Jun; 15 Suppl 1():33-7. PubMed ID: 21595850
[TBL] [Abstract][Full Text] [Related]
8. Tumoral calcinosis revisited: pathophysiology and treatment.
Möckel G; Buttgereit F; Labs K; Perka C
Rheumatol Int; 2005 Jan; 25(1):55-9. PubMed ID: 13680142
[TBL] [Abstract][Full Text] [Related]
9. [Management of secondary hyperparathyroidism].
Cunningham J
Clin Calcium; 2005 Sep; 15 Suppl 1():217-24. PubMed ID: 16279027
[No Abstract] [Full Text] [Related]
10. Cervical tumoral calcinosis with secondary hyperparathyroidism in a chronic hemodialysis patient.
Sunder S; Verma H; Venkataramanan K
Hemodial Int; 2013 Jul; 17(3):458-62. PubMed ID: 23072397
[TBL] [Abstract][Full Text] [Related]
11. Is it worth correcting hyperparathyroidism if hyperphosphatemia and hypocalcemia worsen? A cinacalcet story.
Kalantar-Zadeh K; Kovesdy CP
Am J Kidney Dis; 2009 Feb; 53(2):183-8. PubMed ID: 19166796
[No Abstract] [Full Text] [Related]
12. Regression of parathyroid hyperplasia by calcimimetics--fact or illusion?
Komaba H; Fukagawa M
Nephrol Dial Transplant; 2009 Mar; 24(3):707-9. PubMed ID: 19103739
[No Abstract] [Full Text] [Related]
13. Cost-utility analysis of cinacalcet in addition to standard of care in the UK.
Ray JA; Valentine WJ; Palmer AJ
Nephrol Dial Transplant; 2007 Nov; 22(11):3355-7; author reply 3357-8. PubMed ID: 17785347
[No Abstract] [Full Text] [Related]
14. Use of cinacalcet in a patient on long-term dialysis with end-stage renal failure and refractory secondary hyperparathyroidism.
Dorsch O
Nephrol Dial Transplant; 2007 Feb; 22(2):637-40. PubMed ID: 17095580
[No Abstract] [Full Text] [Related]
15. Cinacalcet versus Parathyroidectomy in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation.
Soliman AR; Maamoun HA; Soliman MA; Darwish H; Elbanna E
Rom J Intern Med; 2016 Sep; 54(3):184-189. PubMed ID: 27658167
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study.
Zitt E; Rix M; Ureña Torres P; Fouque D; Jacobson SH; Pétavy F; Dehmel B; Ryba M
Nephrol Dial Transplant; 2011 Jun; 26(6):1956-61. PubMed ID: 20947534
[TBL] [Abstract][Full Text] [Related]
17. Histopathological alterations of the parathyroid glands in haemodialysis patients with secondary hyperparathyroidism refractory to cinacalcet hydrochloride.
Sumida K; Nakamura M; Ubara Y; Marui Y; Tanaka K; Takaichi K; Tomikawa S; Inoshita N; Ohashi K
J Clin Pathol; 2011 Sep; 64(9):756-60. PubMed ID: 21565858
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of cinacalcet hydrochloride for hemodialysis patients with severe secondary hyperparathyroidism in Japan.
Komaba H; Moriwaki K; Goto S; Yamada S; Taniguchi M; Kakuta T; Kamae I; Fukagawa M
Am J Kidney Dis; 2012 Aug; 60(2):262-71. PubMed ID: 22445709
[TBL] [Abstract][Full Text] [Related]
19. Skin wounds associated with calciphylaxis in end-stage renal disease patients on dialysis.
Sulková SD; Válek M
Nutrition; 2010 Sep; 26(9):910-4. PubMed ID: 20692603
[TBL] [Abstract][Full Text] [Related]
20. Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study.
Evenepoel P; Sprangers B; Lerut E; Bammens B; Claes K; Kuypers D; Meijers B; Vanrenterghem Y
Clin Transplant; 2012; 26(3):393-402. PubMed ID: 22007637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
